Board of Directors

Promethera® Biosciences is strategically advised by a distinguished international board of directors to drive us towards our goal of being the global leader in innovative cell therapies for liver diseases.

Charles L. Dimmler, III

Chairman of the Board

Reiko Namikawa – MD, PhD

Director

Masaki Doi – PhD

Director

Shintaro Hayashi

Director

Edward Haack

Director
Chairman of the Audit Committee

Etienne Sokal – MD, PhD

Founder
Senior Scientific & Medical Advisor
Chairman of the Medical & Scientific Advisory Board

John Tchelingerian – PhD

President & CEO